Update data/rag/knowledge_base/Cryptococcus/laurentii.json
Browse files
data/rag/knowledge_base/Cryptococcus/laurentii.json
CHANGED
|
@@ -0,0 +1,47 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"genus": "Cryptococcus",
|
| 3 |
+
"species": "laurentii",
|
| 4 |
+
"full_name": "Cryptococcus laurentii",
|
| 5 |
+
"clinical_significance": "A rare opportunistic pathogen that primarily affects severely immunocompromised individuals. Associated with fungemia, peritonitis, catheter-related infections, and occasional meningitis. Much less virulent than C. neoformans or C. gattii.",
|
| 6 |
+
"phenotype_profile": {
|
| 7 |
+
"morphology": "Encapsulated budding yeasts, capsule smaller than neoformans/gattii.",
|
| 8 |
+
"culture": "White to cream colonies; does NOT produce melanin on birdseed agar (phenol oxidase negative or weak).",
|
| 9 |
+
"biochemical": [
|
| 10 |
+
"Urease positive",
|
| 11 |
+
"Phenol oxidase weak or negative",
|
| 12 |
+
"Variable thermotolerance (often poor at 37 °C)",
|
| 13 |
+
"Assimilation patterns differ from neoformans complex",
|
| 14 |
+
"No pseudohyphae"
|
| 15 |
+
]
|
| 16 |
+
},
|
| 17 |
+
"differentiation": {
|
| 18 |
+
"from close species": [
|
| 19 |
+
"Does not grow well at 37 °C, unlike neoformans/gattii.",
|
| 20 |
+
"Usually phenol oxidase negative—no melanin production.",
|
| 21 |
+
"Environmental/contaminant unless repeatedly isolated from sterile sites."
|
| 22 |
+
],
|
| 23 |
+
"from other genera": [
|
| 24 |
+
"Urease positivity + capsule distinguish from Candida and Trichosporon.",
|
| 25 |
+
"Lack of melanin helps differentiate from pathogenic cryptococci."
|
| 26 |
+
]
|
| 27 |
+
},
|
| 28 |
+
"virulence_factors": [
|
| 29 |
+
"Capsule (weakly expressed)",
|
| 30 |
+
"Ability to grow in parenteral solutions (rare)",
|
| 31 |
+
"Biofilm formation on catheters"
|
| 32 |
+
],
|
| 33 |
+
"confirmation_methods": [
|
| 34 |
+
"MALDI-TOF MS",
|
| 35 |
+
"ITS sequencing",
|
| 36 |
+
"Phenol oxidase and thermotolerance testing"
|
| 37 |
+
],
|
| 38 |
+
"treatment_notes": [
|
| 39 |
+
"Isolates often susceptible to amphotericin B and fluconazole, but MIC testing recommended.",
|
| 40 |
+
"Remove infected catheters when applicable."
|
| 41 |
+
],
|
| 42 |
+
"notes": "Most isolates represent colonization or contamination; clinical infection is rare.",
|
| 43 |
+
"references": [
|
| 44 |
+
"Cryptococcus laurentii case reports",
|
| 45 |
+
"Environmental basidiomycete taxonomy"
|
| 46 |
+
]
|
| 47 |
+
}
|